Sanofi Consumer Healthcare India (NSE:SANOFICONR) ROE % Adjusted to Book Value: 0.00% (As of Mar. 2026)


NSE:SANOFICONR Sanofi Consumer Healthcare India Ltd NSE:SANOFICONR
32 GF Score
Price ₹4,566.70
! 2 Warning Signs
View Full Analysis

What is Sanofi Consumer Healthcare India ROE % Adjusted to Book Value?

Sanofi Consumer Healthcare India NSE:SANOFICONR +1.34% 32 ROE % Adjusted to Book Value is 0.00% as of Mar. 2026. GuruFocus rates NSE:SANOFICONR with a GF Score™ of 32/100. The stock has 2 warning signs investors should review.

Sanofi Consumer Healthcare India's ROE % for the quarter that ended in Mar. 2026 was 70.63%. Sanofi Consumer Healthcare India's PB Ratio for the quarter that ended in Mar. 2026 was N/A. Sanofi Consumer Healthcare India's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was N/A.

Sanofi Consumer Healthcare India ROE % Adjusted to Book Value Related Terms

Sanofi Consumer Healthcare India ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Sanofi Consumer Healthcare India's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanofi Consumer Healthcare India ROE % Adjusted to Book Value Chart

Sanofi Consumer Healthcare India Annual Data
Trend Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
0.00 1.81 2.70

Sanofi Consumer Healthcare India Quarterly Data
Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 1.85 0.00 2.56 0.00

NSE:SANOFICONR vs LLY, JNJ, ABBV: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - General subindustry, Sanofi Consumer Healthcare India's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sanofi Consumer Healthcare India ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi Consumer Healthcare India's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Sanofi Consumer Healthcare India's ROE % Adjusted to Book Value falls into.


NSE:SANOFICONR
32GF Score
Sanofi Consumer Healthcare India Ltd NSE:SANOFICONR
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sanofi Consumer Healthcare India ROE % Adjusted to Book Value Calculation

Sanofi Consumer Healthcare India's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=73.09% / 27.11
=2.70%

Sanofi Consumer Healthcare India's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=70.63% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a ROE % Adjusted to Book Value of 0.00% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Sanofi Consumer Healthcare India and its competitors.
Is Sanofi Consumer Healthcare India's ROE % Adjusted to Book Value too high?
Sanofi Consumer Healthcare India's current ROE % Adjusted to Book Value is 0.00%. Overall, Sanofi Consumer Healthcare India has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Sanofi Consumer Healthcare India's ROE % Adjusted to Book Value compare to LLY and JNJ?
Sanofi Consumer Healthcare India's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Sanofi Consumer Healthcare India and its competitors. Sanofi Consumer Healthcare India's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanofi Consumer Healthcare India stock overvalued right now?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Sanofi Consumer Healthcare India's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Sanofi Consumer Healthcare India (NSE:SANOFICONR), the current ROE % Adjusted to Book Value is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sanofi Consumer Healthcare India Business Description

Other Exchanges 544250:India
Address Pirojshanagar, Eastern Express Highway, Unit 1104, 11th Floor, Godrej Two, Vikhroli East, Mumbai, MH, IND, 400079
Sanofi Consumer Healthcare India Ltd is mainly engaged in the business of manufacturing and trading of drugs and pharmaceutical products. The Company also has various independent contract/third-party manufacturers based across the country and provides business support services to its group entity in India. Its products include Allergy Relief (Allegra), Pain Care (Combiflam), and Physical Wellness (DePURA). The Company sells its products in India through independent distributors and outside India. Its operations are limited to one segment, namely Pharmaceutical Business. The Company operates in India, which generates the maximum revenue, and Outside India.
32GF Score

Get the complete analysis for NSE:SANOFICONR

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4,566.70
Price